EP3212670
SAMSETT MEÐFERÐ VIÐ KRABBAMEINI
Status:
EP Einkaleyfi fallið úr gildiEP appl. date:
28.10.2015EP published:
23.12.2020EP application number:
15798264.6
EP translation filed:
8.2.2021Grant published:
15.3.2021EPO information:
European Patent Register
Max expiry date:
27.10.2035Expiry date:
27.10.2024
Title:
COMBINATION THERAPY FOR CANCER
Timeline
Today
28.10.2015EP application
23.12.2020EP Publication
8.2.2021Translation submitted
15.3.2021Registration published
27.10.2024Expires
Owner
Name:
Five Prime Therapeutics, Inc.Address:
111 Oyster Point Boulevard, South San Francisco, CA 94080, US
Name:
Bristol-Myers Squibb CompanyAddress:
Route 206 and Province Line Road, Princeton, NJ 08543, US
Inventor
Name:
WONG, BrianAddress:
South San Francisco, California 94080, US
Name:
HAMBLETON, JulieAddress:
South San Francisco, California 94080, US
Name:
SIKORSKI, RobertAddress:
South San Francisco, California 94080, US
Name:
MASTELLER, EmmaAddress:
South San Francisco, California 94080, US
Name:
HESTIR, KevinAddress:
South San Francisco, California 94080, US
Name:
BELLOVIN, DavidAddress:
South San Francisco, California 94080, US
Name:
LEWIS, Katherine E.Address:
Princeton, New Jersey 08543, US
Agent
Name:
G.H. Sigurgeirsson ehf.Address:
Borgartúni 26, 105, Reykjavík,
Priority
Number:
201462072035 PDate:
29.10.2014Country:
US
Number:
201562157368 PDate:
5.5.2015Country:
US
Number:
201562192025 PDate:
13.7.2015Country:
US
Classification
Categories:
C07K 16/28, A61K 39/395, A61P 35/00
Annual fees
Number
Paid
Expires
Payer
Number: 7
Paid: 7.9.2021
Expires: 27.10.2022
Payer: Árnason Faktor ehf.
Number: 8
Paid: 7.9.2022
Expires: 27.10.2023
Payer: Árnason Faktor ehf.
Number: 9
Paid: 13.10.2023
Expires: 27.10.2024
Payer: Árnason Faktor ehf.